A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria
Cells · 25.04.2023 · 12 (9) · 1244
DOI: 10.3390/cells12091244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 25.04.2023. Verfasst von Jessie Qiaoyi Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, …. Hauptthemen laut MEDLINE: Probiotics, Colorectal Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Midstream Research Programme for Universities, ITF, Hong Kong, Croucher Senior Medical Research Fellowship, Hong Kong Ph.D. Fellowship Scheme (HKPFS).
Abstract (Originalsprache)
Gut microbiota dysbiosis with increased pathogenic bacteria and decreased beneficial bacteria is associated with colorectal cancer (CRC) development. This study examined the effect of a newly developed probiotic formula in modulating CRC-related bacteria. We developed a probiotic formula containing three bifidobacteria (B. adolescentis, B. longum, and B. bifidum) based on the identification of bacterial species that showed significant correlations with CRC-related bacteria including Fusobacterium nucleatum (Fn), Lachnoclostridium sp. m3, Clostridium hathewayi (Ch), and Bacteroides clarus (Bc). We co-cultured Fn with each bifidobacterium or the combined formula and examined the growth of Fn by qPCR. The three individual bifidobacteria significantly inhibited the growth of Fn compared to the control treatment (24~65% inhibition; all p < 0.001). The combination of the three bifidobacteria showed a greater inhibitory effect on Fn growth (70% inhibition) than the individual bifidobacteria (all p < 0.05). We further examined the effect of the probiotic formula in a pilot study of 72 subjects (40 on probiotics; 32 with no intervention) for 4 weeks and followed them up for 12 weeks. The relative fecal abundances of the bifidobacteria in the formula and the CRC-related markers (Fn, m3, Ch, and Bc) were quantitated by qPCR before and after the intervention, and the combined CRC risk score (4Bac; Fn, m3, Ch, and Bc) was evaluated. Subjects with probiotics intervention showed significantly increased abundances of the bifidobacteria from week 2 to week 5 compared to baseline (p < 0.05), and the abundances dropped to baseline levels after the cessation of the intervention. There were significant decreases in the levels of CRC-related markers (Fn and m3) and the CRC risk score (4Bac) from week 2 to week 12 compared to baseline levels (p < 0.05) in the intervention group but not in the control group. A novel probiotic formula containing B. adolescentis, B. longum, and B. bifidum was effective in inhibiting the growth of F. nucleatum in vitro and improving the gut microbial environment against CRC development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
- Center for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, China.
- Microbiota I-Center (MagIC), Hong Kong, China.
ORCID-Profile: Jessie Qiaoyi Liang, Zhilu Xu, Jun Yu, Francis Ka Leung Chan
Förderung
- Midstream Research Programme for Universities, ITF, Hong Kong
- Croucher Senior Medical Research Fellowship
- Hong Kong Ph.D. Fellowship Scheme (HKPFS)
Zitieren
APA
Liang, J. Q., Zeng, Y., Lau, E. Y. T., Sun, Y., Huang, Y., Zhou, T., Xu, Z., Yu, J., Ng, S. C., & Chan, F. K. L. (2023). A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria. Cells, 12(9), 1244. https://doi.org/10.3390/cells12091244
Vancouver
Liang JQ, Zeng Y, Lau EYT, Sun Y, Huang Y, Zhou T, et al. A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria. Cells. 2023;12(9):1244. doi:10.3390/cells12091244
BibTeX
@article{Liang2023,
author = {Liang, Jessie Qiaoyi and Zeng, Yao and Lau, Effie Yin Tung and Sun, Yuting and Huang, Yao and Zhou, Tingyu and Xu, Zhilu and Yu, Jun and Ng, Siew Chien and Chan, Francis Ka Leung},
title = {A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria},
journal = {Cells},
year = {2023},
volume = {12},
number = {9},
pages = {1244},
doi = {10.3390/cells12091244}
}
EUVIMED